论文部分内容阅读
近年来 ,支气管哮喘 (简称哮喘 )的发病率呈上升趋势 ,各种高选择性新型的 β2 受体激动剂、胆碱能受体拮抗剂和皮质类固醇等局部吸入剂型在临床上得到了广泛应用 ,不仅减少了药物的副作用 ,而且提高了临床疗效和其安全性。哮喘的各种外治法在协同治疗或巩固治疗中也发挥了一定
In recent years, the incidence of bronchial asthma (asthma) is on the rise, a variety of highly selective new β2 receptor agonists, cholinergic receptor antagonists and corticosteroids and other topical inhalation formulations have been widely used in clinical practice , Not only reduce the side effects of drugs, but also improve the clinical efficacy and safety. A variety of external treatment of asthma in the collaborative treatment or consolidation therapy has also played a certain